Belgium· BE-AMP-SAM072825-00

Noscaflex 15 mg

A noscapine product containing noscapine, registered in Belgium by Ceres Pharmaceuticals. The same ATC class is registered in 8 of our 19 countries.

ATC R05DA07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNoscaflex 15 mgATCR05DA07REGISTER NO.BE-AMP-SAM072825-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Noscapine is registered in 8 of 19 countries.

Countries holding a registration under ATC R05DA07 (noscapine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Noscapine · ATC R05DA07

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Noscapine
Manufacturer
Ceres Pharmaceuticals
Country
Belgium (BE)
ATC code
R05DA07
ATC class
Noscapine
Defined daily dose
0.125 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1359728

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Noscapine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All noscapine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Germany · Capval - Dragees, Capval-Saft
  • Denmark · Noskapin Dak
  • Spain · Tuscalman, Tuscalman Ninos
  • Luxembourg · Nosca Méréprine, Nosca-Méréprine
  • Netherlands · Hoestdrank Noscapine Hcl Etos, Hoestdrank Noscapine Hcl Htp
  • Norway · Noskapin Orifarm Healthcare
  • Sweden · Nipaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e65a8e1a-0107-41a5-881e-d983f4863b6b
GET /v1/drugs/e65a8e1a-0107-41a5-881e-d983f4863b6b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Noscaflex 15 mg",
  "name_fr": "Noscaflex 15 mg",
  "name_nl": "Noscaflex 15 mg",
  "amp_code": "SAM072825-00",
  "strengths": [
    "15.0000",
    "15.0000",
    "15.0000",
    "400.0000",
    "5.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Noscapine",
    "Mannitol",
    "Aspartame"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Noscapine",
  "authorisation_numbers": [
    "BE072825"
  ]
}

See everything about noscapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.